OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
CNSP
CNS Pharmaceuticals, Inc.
Common Stock
0.8755
0.0007
0.08%
Delayed (15 Min) Trade Data: 04:00pm 07/14/2025
CNS Pharmaceuticals, Inc.
2100 West Loop South
Suite 900
Houston, TX 77027
Business Description
CNS Pharmaceuticals a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system malignancies.
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
CIK
0001729427
Fiscal Year End
12/31
Company Officers & Contacts
Not available
Board of Directors
Not available
Other Company Insiders
Not available
Service Providers
Not available
Profile Data
SIC - Industry Classification
2834 - Pharmaceutical preparations
Incorporation Information
NV, US
Employees
Not Available
Shell
No
Products and Services
Not available
Company Facilities
Not available
Company Notes
12(k) Suspension for the period commencing at 9:30 a.m. EDT on May 4, 2020 and terminating at 11:59 p.m. EDT on May 15, 2020.
Loading...
Symbol
OTCM
Last
57.3755
Change
-0.0345 (-0.06%)
Bid
56.30
Ask
57.50
Volume
2472
Time
15:27
